Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study (Q28254501)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study	scientific article

Statements

scholarly article

0 references

Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study (English)

0 references

hypercholesterolemia

0 references

0 references

familial hypercholesterolemia

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

M-a Kawashiri

1

0 references

A Nohara

2

0 references

H Tada

3

0 references

M Mori

4

0 references

M Tsuchida

5

0 references

S Katsuda

6

0 references

A Inazu

7

0 references

J Kobayashi

8

0 references

J Koizumi

9

0 references

H Mabuchi

10

0 references

M Yamagishi

11

0 references

language of work or name

0 references

publication date

May 2008

0 references

Clinical Pharmacology & Therapeutics

0 references

83

0 references

5

0 references

731-9

0 references

Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

21 January 2018

Pitavastatin: efficacy and safety profiles of a novel synthetic HMG-CoA reductase inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

21 January 2018

Relative induction of mRNA for HMG CoA reductase and LDL receptor by five different HMG-CoA reductase inhibitors in cultured human cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

21 January 2018

Distribution of antioxidants among blood components and lipoproteins: significance of lipids/CoQ10 ratio as a possible marker of increased risk for atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

21 January 2018

Influence of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ubiquinone levels in rat skeletal muscle and heart: relationship to cytotoxicity and inhibitory activity for cholesterol synthesis in human skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

21 January 2018

Development of coronary heart disease in familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

21 January 2018

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive versus moderate lipid lowering with statins after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive lipid lowering with atorvastatin in patients with stable coronary disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulatory role for hepatic low density lipoprotein receptors in vivo in the dog

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Coenzyme Q 10 improves lactic acidosis, strokelike episodes, and epilepsy in a patient with MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of simvastatin on plasma antioxidant status and vitamins in hypercholesterolemic patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of HMG-CoA reductase inhibitors on coenzyme Q10: possible biochemical/clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: a randomised trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Withdrawal of cerivastatin from the world market

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular genetic analysis of familial hypercholesterolemia: spectrum and regional difference of LDL receptor gene mutations in Japanese population

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous Detection of Ubiquinol and Ubiquinone in Human Plasma as a Marker of Oxidative Stress

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CLPT.6100396

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.CLPT.6100396

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28254501&oldid=2042800844"